Nitric oxide, a possible mediator of 1,4-dihydropyridine-induced photorelaxation of vascular smooth muscle

British Journal of Pharmacology

Volumn 118, Issue 4, 1996, Pages 879-884

  Lovren, Fina ^a   O'Neill, Sean K ^a   Bieger, Detlef ^b   Igbal, Nadeem ^c   Knaus, Ed E ^c   Triggle, Chris R ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chemiluminescence; Dihydropyridines (DHPs); Nitric oxide; Photorelaxation; Vascular smooth muscle

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 1,4 DIHYDROPYRIDINE; 4 (2,1,3 BENZOOXADIAZOL 4 YL) 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 3 PYRIDINECARBOXYLIC ACID ISOPROPYL ESTER; AMLODIPINE; BICARBONATE; CALCIUM CHLORIDE; FELODIPINE; GLUCOSE; MAGNESIUM SULFATE; NI 102; NI 104; NI 105; NI 72; NI 85; NI 99; NIFEDIPINE; NIMODIPINE; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; RK 30; SODIUM CHLORIDE; STREPTOZOCIN; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LIGHT; NONHUMAN; PHOTOACTIVATION; PHOTODEGRADATION; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0029780406     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15481.x     Document Type: Article

References (22)

1. 2+ channel agonists and antagonists potentiate ultraviolet light-induced relaxation through cyclic GMP formation in porcine coronary artery. J. Cardiovasc. Pharmacol., 23, 785-791.
2. BAUER, J.A. & FUNG, H.L. (1994). Photochemical generation of nitric oxide from nitro containing compounds: possible relation to vascular photorelaxation phenomena. Life Sci., 54, PL 1-4.
3. BLOUGH, N. V. & ZAFIROU, O.C. (1985). Reaction of Superoxide with nitric oxide to form peroxinitrate in alkaline aqueous solution. Inorg. Chem., 24, 3502-4.
4. CHANG, K.C., KIM, Y.S. & LEES, S.Y. (1993). Is the L-arginine/NO pathway involved in photorelaxation in rat aorta? Pharmacol. Commun., 4, 67-75.
5. CHEN, X. & GILLIS, C.N. (1992). Enhanced photorelaxation in aorta, pulmonary artery and corpus cavernosum produced by Bay K 8644 or N-nitro-L-arginine. Biochem. Biophys. Res. Commun., 186, 1522-1527.
6. FURCHGOTT, R.F., EHRREICH, S.J. & GREENBLAT, E. (1961). The photoactivated relaxation of smooth muscle of rabbit aorta. J. Gen. Physiol., 44, 499-519.
7. FURCHGOTT, R.F., MARTIN, W., CHERRY, P.D., JOTHIANANDIAN, D., VILLANI, G.M. (1985). Endothelium-dependent relaxation, photorelaxation and cyclic GMP. In 5th International Symposium, Vascular Neuroeffector Mechanisms. ed. Bevan, J., God-fraind, T., Maxwell, R., Stoclet, J.C. & Worcel, M.P. pp. 105-114. Amsterdam: Elsevier.
8. GOLENHOFEN, K., FINGER, K., FOSTER, B., MANDREK, K. & NOAK, T. (1990). Light induced relaxation of smooth muscle after treatment with Bay K 8644 is related to release of nitric oxide. In Frontiers in Smooth Muscle Research. ed. Sperelakis, N. & Wood, J. pp. 595-604. New York: Wiley-Liss.
9. IGNARRO, L.J., LIPPTON, H., EDWARDS, J.C., BRICOS, W.H., HYMAN, A.L., KADOWITZ, P.J. & GRUETTER, C.A. (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols. J. Pharmacol. Exp. Ther., 218, 738-749.
10. JAKOBSEN, P., PEDERSON, D.L. & MIKKELSEN, E. (1979). Gas chromatography determination of nifedipine and one of its metabolites using electron capture detector. J. Chromatogr., 162, 81-87.
11. LANGS, D.A., KWON, Y.W., STRONG, P.D. & TRIGGLE, D.J. (1991). Molecular level model for lhe agonist/antagonist selectivity of the 1,4-dihydropyridine calcium channel receptor. J. Comput. Aided Mol. Design, 4, 95-106.
12. 3H]-nitrendipine by intact cardiac tissue. Br. J. Pharmacol., 90, 567-573.
13. MARKS, G.S., MCLAUGHLIN, B.E., BROWN, L.B., BEATON, D.E., BOOTH, B.P., NAKATSU, K. & BRIEN, J.F. (1991). Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10.000 × g supernatant: Biotransformation and nitric oxide formation. Can. J. Physiol. Pharmacol., 69, 889-892.
14. 2-1,4-dihydropyridines: evidence for two cyclic GMP-dependent effector pathways. Br. J. Pharmacol., 116, 3293-3301.
15. MATSUNAGA, K. & FURCHGOTT, R.F. (1989). Interaction of light and sodium nitrite in producing relaxation of rabbit aorta. J. Pharmacol. Exp. Ther., 248, 687-695.
16. MIKKELSEN, E. & KAZDA, S. (1985). Effects of light and Bay K 8644, a new 1,4-dihydropyridine on mechanical responses of rat thoracic aorta. Acta Pharmacol. Toxicol., 56, 126-132.
17. NOACK, E. & FEELISCH, M. (1991). Molecular mechanisms of nitrovasodilatator bioactivation. Basic Res. Cardiol. Suppl., 2, 37-50.
18. O'NEILL, S.K., DUTTA, S. & TRIGULE, C.R. (1993). Computerized data acquisition and analysis applied to chemilumincscence detection of nitric oxide in headspace gas. J. Pharmacol. Toxicol. Meth., 29, 217-221.
19. TRIGGLE, C.R. & BIEGER, D. (1990). Can dihydropyridines enhance photorelaxation of smooth muscle by calcium-independent mechanisms? Proc. West Pharmacol., 33, 227-233.
20. TRIGGLE, C.R., O'NEILL, S.K. & BIEGER, D. (1991). NO: role in dihydropyridine enhance photorelaxation of vascular smooth muscle. In Resistance Arteries, Structures and Function ed. Mulvaney, M.J., Aalkjaer, C., Heagerty, A.M., Nyborg, N.C.B. & Straudgaard, S. pp. 233-237. Amsterdam: Elsevier.
21. TRIGGLE, D.J. (1992). Calcium channel antagonists: mechanism of action, vascular selectivities, and clinical relevance [Review]. Cleve. Clin. J. Med., 59, 617-627.
22. 2+ channel function and drug action. Trends Pharmacol. Sci., 16, 43-49.